Increased expression of ACE2 in the biliary epithelium increases susceptibility to SARS-CoV-2 infection, leading to chronic liver disease and providing insights into the potential molecular mechanism underlying biliary tract damage caused by COVID-19 (38, 39). This evidence concerns the gene ACE2 and COVID-19.